The present invention relates to a chemical synthesis route for preparing 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine which compound can be used as an intermediate compound in the synthesis of RSV inhibiting imidazopyridines or imidazopyrimidines.
Respiratory syncytial virus is a major cause of acute lower respiratory tract infection in young children, immunocompromised adults, and the elderly. Intervention with small-molecule antivirals specific for respiratory syncytial virus presents an important therapeutic opportunity, but no such compounds are approved today.
3-Nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine is a compound that can be used as a building block in the synthesis of RSV inhibiting imidazopyridines or imidazopyrimidines such as those disclosed in WO-01/95910.
WO-01/95910 discloses on page 65 the hydrochloric acid salt of 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine which is prepared from 4-methoxy-3-nitro-pyridine as depicted below:
It has now been found that 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine can be prepared conveniently by treating 4-methoxy-3-nitro-pyridine with 2,2,2-trifluoroethylamine in the presence of an aqueous solution comprising an acid under heating.
For large scale production this new synthesis method avoids the use of a high-pressure reaction vessel (i.e. the upscaled version of a sealed tube) and reduced reaction time from 2 days to less than one day (typically between 10 to 16 hours).
The present invention provides a process for preparing 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine of formula (b) by treating 4-methoxy-3-nitro-pyridine of formula (a) with 2,2,2-trifluoroethylamine in the presence of an aqueous solution comprising an acid under heating.
The acid used can be any inorganic or organic acid that is soluble in water and is capable of protonating the pyridine moiety to activate the pyridine ring for nucleophilic substitution. Inorganic acids are selected from hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, boric acid, nitric acid, and the like. Organic acids are preferably carboxylic acids selected from formic acid, acetic acid, p-toluenesulfonic acid, citric acid, oxalic acid, malonic acid, succinic acid, lactic acid, and the like. A suitable organic acid is citric acid, or citric acid monohydrate, which has a low cost, low toxicity and easy to handle. The amount of organic acid can be any amount between 1 mole to 5 mole with respect to the amount of 4-methoxy-3-nitro-pyridine. In practice the amount of organic acid ranges from 1.2 to 3 mole and a preferred range is 1.2 to 1.5.
The amount of 2,2,2-trifluoroethylamine can be any amount between 1 mole to 5 mole with respect to the amount of 4-methoxy-3-nitro-pyridine. In practice the amount of 2,2,2-trifluoroethylamine ranges from 1.1 to 3 mole.
The reaction may conveniently be carried out at a temperature ranging between room temperature and the reflux temperature of the reaction mixture. In practice the temperature can range from room temperature to 90° C., or from 30° C. to 80° C., or from 40° C. to 70° C.
Upon completion of the reaction, the desired 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine can be isolated from the reaction mixture by extraction with an organic solvent.
Citric acid monohoydrate (295.0 g) is dissolved in water (370.0 g) and 4-methoxy-3-nitropyridine (179.0 g) is then added followed by 2,2,2-trifluoroethylamine (348.0 g). The mixture is stirred at 50° C. until complete conversion (10-16 hours). After cooling to room temperature, 2-MeTHF (1250 mL) is added and the mixture is stirred for 1 hour and the phases are then separated. The aqueous phase is re-extracted with 2-MeTHF (530 mL). The combined organic layers are washed with 7% aqueous NaHCO3 solution (890 g) and finally with water (903 g). The organic layer is evaporated to dryness yielding 3-nitro-N-(2,2,2-trifluoroethyl)-4-pyridinamine (233.7 g, 91% yield).
1H NMR (400 MHz, DMSO-d6) δ ppm 4.28-4.47 (m, 2H); 7.28 (d, J=6.27 Hz, 1H); 8.38 (d, J=6.02 Hz, 1H); 8.63 (br t, J=6.65 Hz, 1H); 9.08 (s, 1H)
13C NMR (101 MHz, DMSO-d6) δ ppm 43.15 (q, J=33.0 Hz); 109.30 124.05; 126.84; 130.70; 148.55 (d, J=4.4 Hz); 153.68
Number | Date | Country | Kind |
---|---|---|---|
PCT/CN2019/114253 | Oct 2019 | WO | international |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2020/080379 | 10/29/2020 | WO |